A weak neurotoxin exhibits synergic effect with cardiotoxins when co-applied to two non-neural cell lines.

Biol Pharm Bull

Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing, China.

Published: August 2004

A basic peptide with mass weight of 7.597 kDa was isolated and purified from the Naja atra venom by using the combination of ion exchange chromatography and reverse phase high performance liquid chromatography. N-terminal protein sequence determination revealed that this peptide was a weak neurotoxin. Neurotoxicity and cytotoxicity assay were performed. It was noticed that although the analysis of protein sequence did not show it was much more basic, this neurotoxin was eluted out after a cardiotoxin-like basic protein (CLBP). It was also found that, despite of low neurotoxicity, when applied to two non-neural cell lines including K562 cells and K1735-M2 cells, this weak neurotoxin exhibits synergic effects with cardiotoxins, which is firstly reported. It was presumed that the synergic effect might be due to the presence of their common characteristic tertiary structure, three-finger structure. This fact might bring us some new sights about the functions of the un-lethal components in the complex venom system and may help us to understand how the venom really works as an integrative system.

Download full-text PDF

Source
http://dx.doi.org/10.1248/bpb.27.1241DOI Listing

Publication Analysis

Top Keywords

weak neurotoxin
12
neurotoxin exhibits
8
exhibits synergic
8
non-neural cell
8
cell lines
8
protein sequence
8
synergic cardiotoxins
4
cardiotoxins co-applied
4
co-applied non-neural
4
lines basic
4

Similar Publications

Nonsurgical cosmetic facial procedures have become popular treatment options for individuals seeking aesthetic improvements. Despite a breadth of literature on patient satisfaction with treatment outcomes, there is a lack of information specific to changes in quality of life outcomes. The objective of this umbrella review is to report the effectiveness of nonsurgical facial aesthetic treatments on reported quality of life in cosmetic treatment-seeking patients.

View Article and Find Full Text PDF
Article Synopsis
  • L-(+)-Muscarine (1)-producing mushrooms are extremely dangerous, as consuming them can lead to serious health issues, including death, yet their metabolic properties remain poorly understood.
  • Research identified 4'-phosphomuscarine (2) as a key natural compound in the mycelium of Clitocybe rivulosa, using advanced techniques to confirm its structure, and it was also found in other mushroom species.
  • Muscaridine (3), another related compound, shows weak activation of the muscarinic acetylcholine receptor, highlighting the need for better understanding in emergency medicine to gauge the true risks associated with these toxic mushrooms.
View Article and Find Full Text PDF

Outpatient Infant Botulism in the United States, 1976-2021.

J Pediatr

January 2025

Infant Botulism Treatment and Prevention Program, Infectious Diseases Laboratories Division, Center for Laboratory Sciences, California Department of Public Health, Richmond, CA. Electronic address:

Objective: To characterize cases of outpatients with infant botulism (IB) in the US identified by the Infant Botulism Treatment and Prevention Program at the California Department of Public Health from 1976 through 2021.

Study Design: Outpatient IB cases were defined as patients presenting with an illness consistent with the known paralyzing action of botulinum neurotoxin and with laboratory confirmation. Outpatient cases were distinguished from the majority of patients with IB by the atypical fact that they did not require hospitalization throughout the course of their illness.

View Article and Find Full Text PDF

Botulinum toxin (BTX) is a neurotoxin that has an ability to create a fully reversible relaxation of muscles through decreased release of acethylcholin. It also has an effect on the cholinergic autoimmune nervous system, and it can reduce pain sensitization. BTX is widely used in cosmetic treatments.

View Article and Find Full Text PDF

Rational analysis of data from LC-MS/MS: new insights in acylcarnitines as biomarkers for brain disorders or neurotoxicity.

Front Pharmacol

August 2024

Key Laboratory of Environment and Health, Ministry of Education & Ministry of Environmental Protection and State Key Laboratory of Environmental Health (Incubation), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Article Synopsis
  • LC-MS/MS-based metabolomics is used to study disease biomarkers, specifically through analyzing the effects of Phenobarbital (PHB) poisoning on acylcarnitine levels in plasma and brain tissues.
  • The study effectively employed various statistical methods, including PCA and OPLS-DA, to assess the dose-response relationships and identify potential biomarkers for neurotoxicity.
  • A total of 14 and 11 potential toxicity biomarkers were identified through different screening strategies, with overlap seen in specific acylcarnitines when considering dose-response relationships.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!